HANDBOOK OF GENERAL MEDICINE VOL 1:@0.076190:0.972666:0.349932:0.972666:0.349932:0.958637:0.076190:0.958637:0.009179:0.009945:0.009945:0.009999:0.007714:0.011679:0.011679:0.007943:0.003723:0.011679:0.006518:0.003723:0.011719:0.007203:0.009945:0.007203:0.008158:0.009945:0.006209:0.003723:0.012351:0.007203:0.009999:0.003037:0.010926:0.003037:0.009945:0.007203:0.003723:0.009434:0.011679:0.006209:0.003723:0.007445
74:@0.083944:0.033217:0.104640:0.033217:0.104640:0.013052:0.083944:0.013052:0.010348:0.010348
TREATMENT AppROACHEs:@0.397030:0.032906:0.624375:0.032906:0.624375:0.013617:0.397030:0.013617:0.007872:0.011217:0.009905:0.013674:0.007872:0.016982:0.009905:0.013674:0.007872:0.005119:0.013674:0.010939:0.010939:0.011217:0.016058:0.013674:0.015023:0.012621:0.009905:0.009202
•  Formoterol and mometasone:@0.077870:0.084931:0.311293:0.084931:0.311293:0.069149:0.077870:0.069149:0.009162:0.004188:0.005125:0.007333:0.009903:0.004551:0.014182:0.009903:0.005125:0.009827:0.004551:0.009903:0.003024:0.004188:0.010326:0.009223:0.010357:0.004188:0.014182:0.009903:0.014182:0.009827:0.005125:0.010326:0.005866:0.009903:0.009223:0.009827
•  Salmeterol and fluticasone:@0.077870:0.098936:0.291548:0.098936:0.291548:0.083153:0.077870:0.083153:0.009162:0.004188:0.005125:0.007529:0.010326:0.003024:0.014182:0.009827:0.005125:0.009827:0.004551:0.009903:0.003024:0.004188:0.010326:0.009223:0.010357:0.004188:0.003666:0.003666:0.009192:0.005125:0.003024:0.009782:0.010326:0.005866:0.009903:0.009223:0.009827
•  Vilanterol and fluticasone furoate:@0.077870:0.112941:0.340730:0.112941:0.340730:0.097158:0.077870:0.097158:0.009162:0.004188:0.005125:0.010614:0.003024:0.003024:0.010326:0.009223:0.005125:0.009827:0.004551:0.009903:0.003024:0.004188:0.010326:0.009223:0.010357:0.004188:0.003666:0.003666:0.009192:0.005125:0.003024:0.009782:0.010326:0.005866:0.009903:0.009223:0.009827:0.004188:0.004747:0.009192:0.004551:0.009903:0.010326:0.005125:0.009827
An ICs is combined with a LAMA and LABA as triple :@0.090480:0.126945:0.485132:0.126945:0.485132:0.111163:0.090480:0.111163:0.011188:0.009223:0.005775:0.003417:0.012292:0.007529:0.005775:0.003024:0.005866:0.005791:0.009782:0.009903:0.014182:0.010311:0.003024:0.009223:0.009827:0.010357:0.005775:0.012564:0.003024:0.005125:0.009223:0.005775:0.010326:0.005791:0.006985:0.011188:0.013894:0.011188:0.005775:0.010326:0.009223:0.010357:0.005775:0.006985:0.011188:0.008678:0.011188:0.005775:0.010326:0.005866:0.005791:0.005125:0.004551:0.003024:0.010311:0.003024:0.009827:0.004188
therapy, facilitating the use of three drugs into a once- :@0.076192:0.140950:0.485162:0.140950:0.485162:0.125167:0.076192:0.125167:0.005125:0.009223:0.009827:0.004551:0.010326:0.010311:0.008104:0.004188:0.004717:0.004747:0.010326:0.009782:0.003024:0.003024:0.003024:0.005125:0.010326:0.005125:0.003024:0.009223:0.010175:0.004717:0.005125:0.009223:0.009827:0.004717:0.009192:0.005866:0.009827:0.004717:0.009903:0.004747:0.004717:0.005125:0.009223:0.004551:0.009827:0.009827:0.004702:0.010357:0.004551:0.009192:0.010175:0.005866:0.004717:0.003024:0.009223:0.005125:0.009903:0.004717:0.010326:0.004717:0.009903:0.009223:0.009782:0.009827:0.005020:0.004188
or twice-daily use. Two triple combination inhalers are :@0.076192:0.154954:0.485132:0.154954:0.485132:0.139172:0.076192:0.139172:0.009903:0.004551:0.006063:0.005125:0.012564:0.003024:0.009782:0.009827:0.005020:0.010357:0.010326:0.003024:0.003024:0.008104:0.006078:0.009192:0.005866:0.009827:0.004188:0.006063:0.006441:0.012564:0.009903:0.006063:0.005125:0.004551:0.003024:0.010311:0.003024:0.009827:0.006078:0.009782:0.009903:0.014182:0.010311:0.003024:0.009223:0.010326:0.005125:0.003024:0.009903:0.009223:0.006063:0.003024:0.009223:0.009223:0.010326:0.003024:0.009827:0.004551:0.005866:0.006078:0.010326:0.004551:0.009827:0.004188
available, i.e.:@0.076192:0.168959:0.174360:0.168959:0.174360:0.153176:0.076192:0.153176:0.010326:0.008376:0.010326:0.003024:0.003024:0.010326:0.010311:0.003024:0.009827:0.004188:0.004188:0.003024:0.004188:0.009827:0.004188
•  Fluticasone, umeclidinium and vilanterol – once daily:@0.076192:0.182964:0.480929:0.182964:0.480929:0.167181:0.076192:0.167181:0.009162:0.004188:0.006804:0.007333:0.003024:0.009192:0.005125:0.003024:0.009782:0.010326:0.005866:0.009903:0.009223:0.009827:0.004188:0.003719:0.009192:0.014182:0.009827:0.009782:0.003024:0.003024:0.010357:0.003024:0.009223:0.003024:0.009192:0.014182:0.003719:0.010326:0.009223:0.010357:0.003719:0.008376:0.003024:0.003024:0.010326:0.009223:0.005125:0.009827:0.004551:0.009903:0.003024:0.003719:0.007560:0.003719:0.009903:0.009223:0.009782:0.009827:0.003704:0.010357:0.010326:0.003024:0.003024:0.008104
•  Beclomethasone,  formoterol  and  glycopyrronium  – :@0.076192:0.196968:0.485132:0.196968:0.485132:0.181186:0.076192:0.181186:0.009162:0.004188:0.006804:0.008678:0.009827:0.009782:0.003024:0.009903:0.014182:0.009827:0.005125:0.009223:0.010326:0.005866:0.009903:0.009223:0.009827:0.004188:0.004188:0.002933:0.004747:0.009903:0.004551:0.014182:0.009903:0.005125:0.009827:0.004551:0.009903:0.003024:0.004188:0.002918:0.010326:0.009223:0.010357:0.004188:0.002948:0.010175:0.003024:0.008104:0.009782:0.009903:0.010311:0.008104:0.004551:0.004551:0.009903:0.009223:0.003024:0.009192:0.014182:0.004188:0.002933:0.007560:0.004188
twice daily:@0.096346:0.210973:0.175690:0.210973:0.175690:0.195190:0.096346:0.195190:0.005125:0.012564:0.003024:0.009782:0.009827:0.004188:0.010357:0.010326:0.003024:0.003024:0.008104
The sole use of inhaled corticosteroids is not recom-:@0.090480:0.224978:0.480959:0.224978:0.480959:0.209195:0.090480:0.209195:0.006441:0.009223:0.009827:0.006093:0.005866:0.009903:0.003024:0.009827:0.006108:0.009192:0.005866:0.009827:0.006108:0.009903:0.004747:0.006108:0.003024:0.009223:0.009223:0.010326:0.003024:0.009827:0.010357:0.006108:0.009782:0.009903:0.004551:0.005125:0.003024:0.009782:0.009903:0.005866:0.005125:0.009827:0.004551:0.009903:0.003024:0.010357:0.005866:0.006093:0.003024:0.005866:0.006108:0.009223:0.009903:0.005125:0.006093:0.004551:0.009827:0.009782:0.009903:0.014197:0.005020
mended in COpD.:@0.076192:0.238982:0.210404:0.238982:0.210404:0.223200:0.076192:0.223200:0.014182:0.009827:0.009223:0.010357:0.009827:0.010357:0.004188:0.003024:0.009223:0.004188:0.012292:0.013138:0.008950:0.011249:0.004188
1:@0.210394:0.233624:0.215252:0.233624:0.215252:0.224470:0.210394:0.224470:0.004858
Phosphodiesterase 4 inhibitors:@0.076190:0.268316:0.295719:0.268316:0.295719:0.251818:0.076190:0.251818:0.008467:0.009071:0.009676:0.006652:0.009979:0.009071:0.009676:0.009979:0.003629:0.009676:0.006652:0.004536:0.009676:0.004838:0.009979:0.006652:0.009676:0.004233:0.008467:0.004233:0.003629:0.009071:0.009071:0.003629:0.009979:0.003629:0.004536:0.009676:0.004838:0.006652
Roflumilast  reduces  inflammation  without  any  bron:@0.076190:0.284884:0.475938:0.284884:0.475938:0.269101:0.076190:0.269101:0.009177:0.009903:0.003666:0.003666:0.009192:0.014182:0.003024:0.003024:0.010326:0.005866:0.005125:0.004188:0.006123:0.004551:0.009827:0.010357:0.009192:0.009782:0.009827:0.005866:0.004188:0.006108:0.003024:0.009223:0.003666:0.003666:0.010326:0.014182:0.014182:0.010326:0.005125:0.003024:0.009903:0.009223:0.004188:0.006123:0.012564:0.003024:0.005125:0.009223:0.009903:0.009192:0.005125:0.004188:0.006108:0.010326:0.009223:0.008104:0.004188:0.006123:0.010311:0.004551:0.009903:0.009223
-:@0.475938:0.284884:0.480957:0.284884:0.480957:0.269101:0.475938:0.269101:0.005020
chodilatation. It is  used in conjunction  with inhaled :@0.076190:0.298888:0.485115:0.298888:0.485115:0.283106:0.076190:0.283106:0.009782:0.009223:0.009903:0.010357:0.003024:0.003024:0.010326:0.005125:0.010326:0.005125:0.003024:0.009903:0.009223:0.004188:0.009268:0.003417:0.005125:0.009268:0.003024:0.005866:0.004188:0.005095:0.009192:0.005866:0.009827:0.010357:0.009268:0.003024:0.009223:0.009268:0.009782:0.009903:0.009223:0.003069:0.009192:0.009223:0.009782:0.005125:0.003024:0.009903:0.009223:0.004188:0.005065:0.012564:0.003024:0.005125:0.009223:0.009268:0.003024:0.009223:0.009223:0.010326:0.003024:0.009827:0.010357:0.004188
corticosteroids as a once-daily oral dose. It reduces ex-:@0.076190:0.312893:0.480942:0.312893:0.480942:0.297110:0.076190:0.297110:0.009782:0.009903:0.004551:0.005125:0.003024:0.009782:0.009903:0.005866:0.005125:0.009827:0.004551:0.009903:0.003024:0.010357:0.005866:0.004369:0.010326:0.005866:0.004385:0.010326:0.004385:0.009903:0.009223:0.009782:0.009827:0.005020:0.010357:0.010326:0.003024:0.003024:0.008104:0.004385:0.009903:0.004551:0.010326:0.003024:0.004385:0.010357:0.009903:0.005866:0.009827:0.004188:0.004385:0.003417:0.005125:0.004385:0.004551:0.009827:0.010357:0.009192:0.009782:0.009827:0.005866:0.004385:0.009827:0.007257:0.005020
acerbations in severe COpD patients. There are, how-:@0.076190:0.326898:0.480972:0.326898:0.480972:0.311115:0.076190:0.311115:0.010326:0.009782:0.009827:0.004551:0.010311:0.010326:0.005125:0.003024:0.009903:0.009223:0.005866:0.005987:0.003024:0.009223:0.005987:0.005866:0.009827:0.008376:0.009827:0.004551:0.009827:0.005987:0.012292:0.013138:0.008950:0.011249:0.005987:0.010311:0.010326:0.005125:0.003024:0.009827:0.009223:0.005125:0.005866:0.004188:0.005987:0.006441:0.009223:0.009827:0.004551:0.009827:0.005972:0.010326:0.004551:0.009827:0.004188:0.005972:0.009223:0.009903:0.012564:0.005020
ever,  significant  side  effects,  e.g.  nausea,  diarrhoea, :@0.076190:0.340902:0.485160:0.340902:0.485160:0.325120:0.076190:0.325120:0.009827:0.008376:0.009827:0.004551:0.004188:0.004188:0.003825:0.005866:0.003024:0.010175:0.009223:0.003024:0.003681:0.003681:0.009782:0.010326:0.009223:0.005125:0.004188:0.003825:0.005866:0.003024:0.010357:0.009827:0.004188:0.003840:0.009827:0.004747:0.004747:0.009827:0.009782:0.005125:0.005866:0.004188:0.004188:0.003825:0.009827:0.004188:0.010175:0.004188:0.004188:0.003825:0.009223:0.010326:0.009192:0.005866:0.009827:0.010326:0.004188:0.004188:0.003825:0.010357:0.003024:0.010326:0.004551:0.004551:0.009223:0.009903:0.009827:0.010326:0.004188:0.004188
abdominal pain, insomnia and headache, to name but :@0.076190:0.354907:0.485130:0.354907:0.485130:0.339124:0.076190:0.339124:0.010326:0.010311:0.010357:0.009903:0.014182:0.003024:0.009223:0.010326:0.003024:0.003719:0.010311:0.010326:0.003024:0.009223:0.004188:0.003719:0.003024:0.009223:0.005866:0.009903:0.014182:0.009223:0.003024:0.010326:0.003719:0.010326:0.009223:0.010357:0.003719:0.009223:0.009827:0.010326:0.010357:0.010326:0.009782:0.009223:0.009827:0.004188:0.003719:0.005125:0.009903:0.003719:0.009223:0.010326:0.014182:0.009827:0.003719:0.010311:0.009192:0.005125:0.004188
a few.:@0.076190:0.368911:0.122031:0.368911:0.122031:0.353129:0.076190:0.353129:0.010326:0.004188:0.004747:0.009827:0.012564:0.004188
1:@0.122027:0.363577:0.126886:0.363577:0.126886:0.354424:0.122027:0.354424:0.004858
mucolytics :@0.076190:0.398269:0.159345:0.398269:0.159345:0.381771:0.076190:0.381771:0.013607:0.009071:0.009676:0.009676:0.003629:0.008769:0.004536:0.003629:0.009676:0.006652:0.004233
The  use of  mucolytics is controversial. There  is a small :@0.076190:0.414837:0.485130:0.414837:0.485130:0.399054:0.076190:0.399054:0.006441:0.009223:0.009827:0.004188:0.002434:0.009192:0.005866:0.009827:0.006637:0.009903:0.004747:0.004188:0.002434:0.014182:0.009192:0.009782:0.009903:0.003024:0.008104:0.005125:0.003024:0.009782:0.005866:0.006637:0.003024:0.005866:0.006637:0.009782:0.009903:0.009223:0.005110:0.004551:0.009903:0.008376:0.009827:0.004551:0.005866:0.003024:0.010326:0.003024:0.004188:0.006637:0.006441:0.009223:0.009827:0.004551:0.009827:0.004188:0.002434:0.003024:0.005866:0.006637:0.010326:0.006637:0.005866:0.014182:0.010326:0.003024:0.003024:0.004188
quality of life benefit from pooled data that showed that :@0.076190:0.428842:0.485145:0.428842:0.485145:0.413059:0.076190:0.413059:0.010311:0.009192:0.010326:0.003024:0.003024:0.005125:0.008104:0.003175:0.009903:0.004747:0.003175:0.003024:0.003024:0.004747:0.009827:0.003175:0.010311:0.009827:0.009223:0.009827:0.003681:0.003681:0.005125:0.003160:0.004747:0.004551:0.009903:0.014182:0.003160:0.010311:0.009903:0.009903:0.003024:0.009827:0.010357:0.003175:0.010357:0.010326:0.005125:0.010326:0.003175:0.005125:0.009223:0.010326:0.005125:0.003160:0.005866:0.009223:0.009903:0.012564:0.009827:0.010357:0.003175:0.005125:0.009223:0.010326:0.005125:0.004188
one exacerbation is prevented every three years.  se-:@0.076190:0.442846:0.480958:0.442833:0.480958:0.427050:0.076190:0.427064:0.009903:0.009223:0.009827:0.005110:0.009827:0.007257:0.010326:0.009782:0.009827:0.004551:0.010311:0.010326:0.005125:0.003024:0.009903:0.009223:0.005110:0.003024:0.005866:0.005125:0.010311:0.004551:0.009827:0.008376:0.009827:0.009223:0.005125:0.009827:0.010357:0.005110:0.009827:0.008376:0.009827:0.004551:0.008104:0.005125:0.005125:0.009223:0.004551:0.009827:0.009827:0.005110:0.008104:0.009827:0.010326:0.004551:0.005866:0.004188:0.009722:0.005125:0.007529:0.009827:0.274353
13:@0.443737:0.437534:0.453453:0.437534:0.453453:0.428380:0.443737:0.428380:0.004858:0.004858
lected COpD populations that produce large amounts :@0.076191:0.456837:0.485146:0.456837:0.485146:0.441055:0.076191:0.441055:0.003024:0.009827:0.009782:0.005125:0.009827:0.010357:0.004929:0.012292:0.013138:0.008950:0.011249:0.004929:0.010311:0.009903:0.010311:0.009192:0.003024:0.010326:0.005125:0.003024:0.009903:0.009223:0.005866:0.004929:0.005125:0.009223:0.010326:0.005125:0.004914:0.010311:0.004551:0.009903:0.010357:0.009192:0.009782:0.009827:0.004914:0.003024:0.010326:0.004551:0.010175:0.009827:0.004929:0.010326:0.014182:0.009903:0.009192:0.009223:0.005125:0.005866:0.004188
of sputum may benefit from the use of mucolytics.:@0.076191:0.470842:0.441769:0.470842:0.441769:0.455059:0.076191:0.455059:0.009903:0.004747:0.004188:0.005866:0.010311:0.009192:0.005125:0.009192:0.014182:0.004188:0.014182:0.010326:0.008104:0.004188:0.010311:0.009827:0.009223:0.009827:0.003681:0.003681:0.005125:0.004188:0.004747:0.004551:0.009903:0.014182:0.004188:0.005125:0.009223:0.009827:0.004188:0.009192:0.005866:0.009827:0.004188:0.009903:0.004747:0.004188:0.014182:0.009192:0.009782:0.009903:0.003024:0.008104:0.005125:0.003024:0.009782:0.005866:0.004188
1:@0.441727:0.465532:0.446585:0.465532:0.446585:0.456378:0.441727:0.456378:0.004858
Antibiotics:@0.076190:0.500224:0.152390:0.500224:0.152390:0.483726:0.076190:0.483726:0.011188:0.009071:0.004536:0.003629:0.009979:0.003629:0.009676:0.004536:0.003629:0.009676:0.006652
The  long-term  use of  azithromycin or  erythromycin  re-:@0.076190:0.516792:0.480957:0.516792:0.480957:0.501009:0.076190:0.501009:0.006441:0.009223:0.009827:0.004188:0.002434:0.003024:0.009903:0.009223:0.010175:0.005020:0.005125:0.009827:0.004551:0.014182:0.004188:0.002434:0.009192:0.005866:0.009827:0.006637:0.009903:0.004747:0.004188:0.002434:0.010326:0.006426:0.003024:0.005125:0.009223:0.004551:0.009903:0.014167:0.008104:0.009782:0.003024:0.009223:0.006637:0.009903:0.004551:0.004188:0.002434:0.009827:0.004551:0.008104:0.005125:0.009223:0.004551:0.009903:0.014182:0.008104:0.009782:0.003024:0.009223:0.004188:0.002434:0.004551:0.009827:0.005020
duces the exacerbation rate of COpD; however bac-:@0.076190:0.530797:0.480942:0.530797:0.480942:0.515014:0.076190:0.515014:0.010357:0.009192:0.009782:0.009827:0.005866:0.006017:0.005125:0.009223:0.009827:0.006002:0.009827:0.007257:0.010326:0.009782:0.009827:0.004551:0.010311:0.010326:0.005125:0.003024:0.009903:0.009223:0.006002:0.004551:0.010326:0.005125:0.009827:0.006017:0.009903:0.004747:0.006002:0.012292:0.013138:0.008950:0.011249:0.004188:0.006017:0.009223:0.009903:0.012564:0.009827:0.008376:0.009827:0.004551:0.006002:0.010311:0.010326:0.009782:0.005020
terial resistance may develop. Corrected  QT-interval :@0.076190:0.544801:0.485115:0.544801:0.485115:0.529019:0.076190:0.529019:0.005125:0.009827:0.004551:0.003024:0.010326:0.003024:0.008542:0.004551:0.009827:0.005866:0.003024:0.005866:0.005125:0.010326:0.009223:0.009782:0.009827:0.008542:0.014182:0.010326:0.008104:0.008542:0.010357:0.009827:0.008376:0.009827:0.003024:0.009903:0.010311:0.004188:0.008542:0.012292:0.009903:0.004551:0.004551:0.009827:0.009782:0.005125:0.009827:0.010357:0.004188:0.004339:0.013169:0.006441:0.005020:0.003024:0.009223:0.005125:0.009827:0.004551:0.008376:0.010326:0.003024:0.004188
( QT), interval ECG-monitoring and audiometry testing :@0.076190:0.558806:0.485130:0.558806:0.485130:0.543023:0.076190:0.543023:0.005579:0.009782:0.013169:0.006441:0.005579:0.004188:0.005352:0.003024:0.009223:0.005125:0.009827:0.004551:0.008376:0.010326:0.003024:0.005352:0.008104:0.012292:0.013184:0.005020:0.014182:0.009903:0.009223:0.003024:0.005125:0.009903:0.004551:0.003024:0.009223:0.010175:0.005337:0.010326:0.009223:0.010357:0.005352:0.010326:0.009192:0.010357:0.003024:0.009903:0.014182:0.009827:0.005125:0.004551:0.008104:0.005352:0.005125:0.009827:0.005866:0.005125:0.003024:0.009223:0.010175:0.004188
c:@0.081769:0.558806:0.091551:0.558806:0.091551:0.543023:0.081769:0.543023:0.009782
for ototoxicity are required. The subpopulation group of :@0.076190:0.572810:0.485160:0.572810:0.485160:0.557028:0.076190:0.557028:0.004747:0.009903:0.004551:0.004112:0.009903:0.005125:0.009903:0.005125:0.009888:0.007257:0.003024:0.009782:0.003024:0.005125:0.008104:0.004127:0.010326:0.004551:0.009827:0.004112:0.004551:0.009827:0.010311:0.009192:0.003024:0.004551:0.009827:0.010357:0.004188:0.004112:0.006441:0.009223:0.009827:0.004112:0.005866:0.009192:0.010311:0.010311:0.009903:0.010311:0.009192:0.003024:0.010326:0.005125:0.003024:0.009903:0.009223:0.004112:0.010175:0.004551:0.009903:0.009192:0.010311:0.004112:0.009903:0.004747:0.004188
COPD  patients  who  may  benefit  the  most  from  mac:@0.076190:0.586815:0.475923:0.586815:0.475923:0.571032:0.076190:0.571032:0.012292:0.013138:0.008950:0.011249:0.004188:0.002359:0.010311:0.010326:0.005125:0.003024:0.009827:0.009223:0.005125:0.005866:0.004188:0.002359:0.012564:0.009223:0.009903:0.004188:0.002359:0.014182:0.010326:0.008104:0.004188:0.002359:0.010311:0.009827:0.009223:0.009827:0.003681:0.003681:0.005125:0.004188:0.002359:0.005125:0.009223:0.009827:0.004188:0.002359:0.014182:0.009903:0.005866:0.005125:0.004188:0.002359:0.004747:0.004551:0.009903:0.014182:0.004188:0.002359:0.014182:0.010326:0.009782
-:@0.475923:0.586815:0.480942:0.586815:0.480942:0.571032:0.475923:0.571032:0.005020
rolides are those older than 65 who suffer frequent ex-:@0.076190:0.600820:0.480942:0.600820:0.480942:0.585037:0.076190:0.585037:0.004551:0.009903:0.003024:0.003024:0.010357:0.009827:0.005866:0.005534:0.010326:0.004551:0.009827:0.005518:0.005125:0.009223:0.009903:0.005866:0.009827:0.005534:0.009903:0.003024:0.010357:0.009827:0.004551:0.005518:0.005125:0.009223:0.010326:0.009223:0.005518:0.008376:0.008376:0.005534:0.012564:0.009223:0.009903:0.005518:0.005866:0.009192:0.004747:0.004747:0.009827:0.004551:0.005518:0.004747:0.004551:0.009827:0.010311:0.009192:0.009827:0.009223:0.005125:0.005518:0.009827:0.007257:0.005020
acerbation with moderate to severe COpD. The recom-:@0.076190:0.614824:0.480957:0.614824:0.480957:0.599042:0.076190:0.599042:0.010326:0.009782:0.009827:0.004551:0.010311:0.010326:0.005125:0.003024:0.009903:0.009223:0.003780:0.012564:0.003024:0.005125:0.009223:0.003780:0.014182:0.009903:0.010357:0.009827:0.004551:0.010326:0.005125:0.009827:0.003780:0.005125:0.009903:0.003780:0.005866:0.009827:0.008376:0.009827:0.004551:0.009827:0.003780:0.012292:0.013138:0.008950:0.011249:0.004188:0.003780:0.006441:0.009223:0.009827:0.003780:0.004551:0.009827:0.009782:0.009903:0.014182:0.005020
mended  dosing  is three  times a week.   There  are  no :@0.076190:0.628829:0.485136:0.628783:0.485136:0.613000:0.076190:0.613046:0.014182:0.009827:0.009223:0.010357:0.009827:0.010357:0.004188:0.002389:0.010357:0.009903:0.005866:0.003024:0.009223:0.010175:0.004188:0.002389:0.003024:0.005866:0.006592:0.005125:0.009223:0.004551:0.009827:0.009827:0.004188:0.002389:0.005125:0.003024:0.014182:0.009827:0.005866:0.006592:0.010326:0.006592:0.012564:0.009827:0.009827:0.007590:0.004188:0.009712:0.004188:0.002389:0.006441:0.009223:0.009827:0.004551:0.009827:0.004188:0.002389:0.010326:0.004551:0.009827:0.004188:0.002389:0.009223:0.009903:0.025837
14:@0.367799:0.623484:0.377515:0.623484:0.377515:0.614330:0.367799:0.614330:0.004858:0.004858
studies to demonstrate  therapy for a longer  duration :@0.076196:0.642788:0.485151:0.642788:0.485151:0.627005:0.076196:0.627005:0.005866:0.005125:0.009192:0.010357:0.003024:0.009827:0.005866:0.007257:0.005125:0.009903:0.007257:0.010357:0.009827:0.014182:0.009903:0.009223:0.005866:0.005125:0.004551:0.010326:0.005125:0.009827:0.004188:0.003054:0.005125:0.009223:0.009827:0.004551:0.010326:0.010311:0.008104:0.007257:0.004747:0.009903:0.004551:0.007257:0.010326:0.007257:0.003024:0.009903:0.009223:0.010175:0.009827:0.004551:0.004188:0.003054:0.010357:0.009192:0.004551:0.010326:0.005125:0.003024:0.009903:0.009223:0.004188
than one year.:@0.076196:0.656792:0.184418:0.656792:0.184418:0.641010:0.076196:0.641010:0.005125:0.009223:0.010326:0.009223:0.004188:0.009903:0.009223:0.009827:0.004188:0.008104:0.009827:0.010326:0.004551:0.004188
1 :@0.184393:0.651483:0.191680:0.651483:0.191680:0.642329:0.184393:0.642329:0.004858:0.002429
Domiciliary oxygen :@0.076190:0.686175:0.222543:0.686175:0.222543:0.669676:0.076190:0.669676:0.010583:0.009676:0.014212:0.003629:0.009676:0.003629:0.003629:0.003629:0.009979:0.004838:0.008769:0.004233:0.009676:0.008467:0.008769:0.009979:0.009676:0.009071:0.004233
Oxygen requirement assessment is  needed when the :@0.076190:0.702742:0.485160:0.702742:0.485160:0.686960:0.076190:0.686960:0.013138:0.007257:0.008104:0.010175:0.009827:0.009223:0.007015:0.004551:0.009827:0.010311:0.009192:0.003024:0.004551:0.009827:0.014182:0.009827:0.009223:0.005125:0.007015:0.010326:0.005866:0.005866:0.009827:0.005866:0.005866:0.014197:0.009827:0.009223:0.005125:0.007015:0.003024:0.005866:0.004188:0.002842:0.009223:0.009827:0.009827:0.010357:0.009827:0.010357:0.007015:0.012564:0.009223:0.009827:0.009223:0.007015:0.005125:0.009223:0.009827:0.004188
patient has a room oxygen saturation of  88% or  paO:@0.076190:0.716608:0.476089:0.716608:0.476089:0.700826:0.076190:0.700826:0.010311:0.010326:0.005125:0.003024:0.009827:0.009223:0.005125:0.004127:0.009223:0.010326:0.005866:0.004143:0.010326:0.004143:0.004551:0.009903:0.009903:0.014182:0.004127:0.009903:0.007257:0.008104:0.010175:0.009827:0.009223:0.004127:0.005866:0.010326:0.005125:0.009192:0.004551:0.010326:0.005125:0.003024:0.009903:0.009223:0.004127:0.009903:0.004747:0.004188:0.009102:0.008376:0.008376:0.011717:0.004143:0.009903:0.004551:0.004188:0.009102:0.008950:0.010326:0.013138
<:@0.374156:0.716608:0.383318:0.716608:0.383318:0.700826:0.374156:0.700826:0.009162
<:@0.434512:0.716608:0.443674:0.716608:0.443674:0.700826:0.434512:0.700826:0.009162
2 :@0.476092:0.716276:0.483379:0.716276:0.483379:0.707122:0.476092:0.707122:0.004858:0.002429
55 mmHg in two readings over three weeks. Alternative-:@0.076190:0.730995:0.480957:0.730995:0.480957:0.715212:0.076190:0.715212:0.008376:0.008376:0.003356:0.014182:0.014182:0.010326:0.010175:0.003356:0.003024:0.009223:0.003356:0.005125:0.012564:0.009903:0.003356:0.004551:0.009827:0.010326:0.010357:0.003024:0.009223:0.010175:0.005866:0.003356:0.009903:0.008376:0.009827:0.004551:0.003356:0.005125:0.009223:0.004551:0.009827:0.009827:0.003341:0.012564:0.009827:0.009827:0.007590:0.005866:0.004188:0.006773:0.011188:0.003024:0.005125:0.009827:0.004551:0.009223:0.010326:0.005125:0.003024:0.008376:0.009827:0.005020
1 :@0.389517:0.725696:0.396804:0.725696:0.396804:0.716542:0.389517:0.716542:0.004858:0.002429
ly, domiciliary oxygen should be considered if there are :@0.076190:0.745380:0.485130:0.745380:0.485130:0.729598:0.076190:0.729598:0.003024:0.008104:0.004188:0.004279:0.010357:0.009903:0.014182:0.003024:0.009782:0.003024:0.003024:0.003024:0.010326:0.004551:0.008104:0.004279:0.009903:0.007257:0.008104:0.010175:0.009827:0.009223:0.004264:0.005866:0.009223:0.009903:0.009192:0.003024:0.010357:0.004279:0.010311:0.009827:0.004279:0.009782:0.009903:0.009223:0.005866:0.003024:0.010357:0.009827:0.004551:0.009827:0.010357:0.004279:0.003024:0.004747:0.004279:0.005125:0.009223:0.009827:0.004551:0.009827:0.004264:0.010326:0.004551:0.009827:0.004188
signs of right ventricular failure, pulmonary hypertension :@0.076190:0.759766:0.485145:0.759766:0.485145:0.743983:0.076190:0.743983:0.005866:0.003024:0.010175:0.009223:0.005866:0.004173:0.009903:0.004747:0.004158:0.004551:0.003024:0.010175:0.009223:0.005125:0.004158:0.008376:0.009827:0.009223:0.005125:0.004551:0.003024:0.009782:0.009192:0.003024:0.010326:0.004551:0.004158:0.004747:0.010326:0.003024:0.003024:0.009192:0.004551:0.009827:0.004188:0.004158:0.010311:0.009192:0.003024:0.014182:0.009903:0.009223:0.010326:0.004551:0.008104:0.004158:0.009223:0.008104:0.010311:0.009827:0.004551:0.005125:0.009827:0.009223:0.005866:0.003024:0.009903:0.009223:0.004188
or polycythaemia with a haematocrit >55% with paO  :@0.519047:0.084931:0.927997:0.084931:0.927997:0.069149:0.519047:0.069149:0.009903:0.004551:0.006078:0.010311:0.009903:0.003024:0.008104:0.009782:0.008104:0.005125:0.009223:0.010326:0.009827:0.014182:0.003024:0.010326:0.006078:0.012564:0.003024:0.005125:0.009223:0.006078:0.010326:0.006078:0.009223:0.010326:0.009827:0.014182:0.010326:0.005125:0.009903:0.009782:0.004551:0.003024:0.005125:0.006078:0.009162:0.008376:0.008376:0.011717:0.006078:0.012564:0.003024:0.005125:0.009223:0.006078:0.008950:0.010326:0.013138:0.004863:0.004188
2:@0.918949:0.084597:0.923807:0.084597:0.923807:0.075443:0.918949:0.075443:0.004858
of 55-60 mmHg.:@0.519042:0.099167:0.633644:0.099167:0.633644:0.083384:0.519042:0.083384:0.009903:0.004747:0.004188:0.008376:0.008376:0.005020:0.008376:0.008376:0.004188:0.014182:0.014182:0.010326:0.010175:0.004188
1:@0.633651:0.093871:0.638509:0.093871:0.638509:0.084717:0.633651:0.084717:0.004858
Follow-up management entails assessing inhaler tech-:@0.533333:0.113407:0.923812:0.113407:0.923812:0.097625:0.533333:0.097625:0.007333:0.009903:0.003024:0.003024:0.009903:0.012564:0.005020:0.009192:0.010311:0.003432:0.014182:0.010326:0.009223:0.010326:0.010175:0.009827:0.014182:0.009827:0.009223:0.005125:0.003417:0.009827:0.009223:0.005125:0.010326:0.003024:0.003024:0.005866:0.003432:0.010326:0.005866:0.005866:0.009827:0.005866:0.005866:0.003024:0.009223:0.010175:0.003447:0.003024:0.009223:0.009223:0.010326:0.003024:0.009827:0.004551:0.003432:0.005125:0.009827:0.009782:0.009223:0.005020
nique,  smoking  cessation,  vaccination, and symptom :@0.519045:0.127643:0.927985:0.127643:0.927985:0.111860:0.519045:0.111860:0.009223:0.003024:0.010311:0.009192:0.009827:0.004188:0.004188:0.003009:0.005866:0.014182:0.009903:0.007590:0.003024:0.009223:0.010175:0.004188:0.003009:0.009782:0.009827:0.005866:0.005866:0.010326:0.005125:0.003024:0.009903:0.009223:0.004188:0.004188:0.003009:0.008376:0.010326:0.009782:0.009782:0.003024:0.009223:0.010326:0.005125:0.003024:0.009903:0.009223:0.004188:0.007212:0.010326:0.009223:0.010357:0.007212:0.005866:0.008104:0.014182:0.010311:0.005125:0.009903:0.014182:0.004188
management  to  determine  whether  the  patient has :@0.519045:0.141878:0.927970:0.141878:0.927970:0.126096:0.519045:0.126096:0.014182:0.010326:0.009223:0.010326:0.010175:0.009827:0.014182:0.009827:0.009223:0.005125:0.004188:0.003886:0.005125:0.009903:0.004188:0.003886:0.010357:0.009827:0.005125:0.009827:0.004551:0.014182:0.003024:0.009223:0.009827:0.004188:0.003886:0.012564:0.009223:0.009827:0.005125:0.009223:0.009827:0.004551:0.004188:0.003886:0.005125:0.009223:0.009827:0.004188:0.003886:0.010311:0.010326:0.005125:0.003024:0.009827:0.009223:0.005125:0.008089:0.009223:0.010326:0.005866:0.004188
greater dyspnoea or exacerbations of COpD. Therapy :@0.519045:0.156114:0.927985:0.156114:0.927985:0.140331:0.519045:0.140331:0.010175:0.004551:0.009827:0.010326:0.005125:0.009827:0.004551:0.005564:0.010357:0.008104:0.005866:0.010311:0.009223:0.009903:0.009827:0.010326:0.005579:0.009903:0.004551:0.005564:0.009827:0.007257:0.010326:0.009782:0.009827:0.004551:0.010311:0.010326:0.005125:0.003024:0.009903:0.009223:0.005866:0.005564:0.009903:0.004747:0.005564:0.012292:0.013138:0.008950:0.011249:0.004188:0.005564:0.006441:0.009223:0.009827:0.004551:0.010326:0.010311:0.008104:0.004188
is then modified accordingly, as outlined in Table 2.:@0.519045:0.170349:0.892894:0.170349:0.892894:0.154567:0.519045:0.154567:0.003024:0.005866:0.004188:0.005125:0.009223:0.009827:0.009223:0.004188:0.014182:0.009903:0.010357:0.003024:0.003681:0.003681:0.009827:0.010357:0.004188:0.010326:0.009782:0.009782:0.009903:0.004551:0.010357:0.003024:0.009223:0.010175:0.003024:0.008104:0.004188:0.004188:0.010326:0.005866:0.004188:0.009903:0.009192:0.005125:0.003024:0.003024:0.009223:0.009827:0.010357:0.004188:0.003024:0.009223:0.004188:0.006441:0.010326:0.010311:0.003024:0.009827:0.004188:0.008376:0.004188
Consider adding ICs when eosinophil count  >300 :@0.533333:0.184585:0.927985:0.184585:0.927985:0.168802:0.533333:0.168802:0.012292:0.009903:0.009223:0.005866:0.003024:0.010357:0.009827:0.004551:0.009510:0.010326:0.010357:0.010357:0.003024:0.009223:0.010175:0.009510:0.003417:0.012292:0.007529:0.009510:0.012564:0.009223:0.009827:0.009223:0.009510:0.009827:0.009903:0.005866:0.003024:0.009223:0.009903:0.010311:0.009223:0.003024:0.003024:0.009510:0.009782:0.009903:0.009192:0.009223:0.005125:0.004188:0.005307:0.009162:0.008376:0.008376:0.008376:0.004188
cells/µL or  >100 cells/µL and  >2 moderate  exacerba-:@0.519045:0.198820:0.923812:0.198820:0.923812:0.183038:0.519045:0.183038:0.009782:0.009827:0.003024:0.003024:0.005866:0.006607:0.008709:0.006985:0.007091:0.009903:0.004551:0.004188:0.002888:0.009162:0.008376:0.008376:0.008376:0.007091:0.009782:0.009827:0.003024:0.003024:0.005866:0.006607:0.008709:0.006985:0.007091:0.010326:0.009223:0.010357:0.004188:0.002903:0.009162:0.008376:0.007091:0.014182:0.009903:0.010357:0.009827:0.004551:0.010326:0.005125:0.009827:0.004188:0.002888:0.009827:0.007257:0.010326:0.009782:0.009827:0.004551:0.010311:0.010326:0.005020
tions or one hospitalisation.:@0.519045:0.213056:0.715638:0.213056:0.715638:0.197273:0.519045:0.197273:0.005125:0.003024:0.009903:0.009223:0.005866:0.004188:0.009903:0.004551:0.004188:0.009903:0.009223:0.009827:0.004188:0.009223:0.009903:0.005866:0.010311:0.003024:0.005125:0.010326:0.003024:0.003024:0.005866:0.010326:0.005125:0.003024:0.009903:0.009223:0.004188
1:@0.715624:0.207774:0.720482:0.207774:0.720482:0.198620:0.715624:0.198620:0.004858
COmOrbiDities in COPD:@0.519047:0.246058:0.740424:0.246058:0.740424:0.225893:0.519047:0.225893:0.014413:0.015522:0.016631:0.015522:0.010718:0.010718:0.005174:0.012935:0.005174:0.007761:0.005174:0.009609:0.009609:0.005174:0.005174:0.013674:0.005174:0.014413:0.015522:0.010348:0.012935
COpD has an increased incidence of the following co-:@0.519047:0.262074:0.923829:0.262074:0.923829:0.246291:0.519047:0.246291:0.012292:0.013138:0.008950:0.011249:0.004778:0.009223:0.010326:0.005866:0.004778:0.010326:0.009223:0.004778:0.003024:0.009223:0.009782:0.004551:0.009827:0.010326:0.005866:0.009827:0.010357:0.004778:0.003024:0.009223:0.009782:0.003024:0.010357:0.009827:0.009223:0.009782:0.009827:0.004778:0.009903:0.004747:0.004778:0.005125:0.009223:0.009827:0.004778:0.004747:0.009903:0.003024:0.003024:0.009903:0.012564:0.003024:0.009223:0.010175:0.004778:0.009782:0.009903:0.005020
morbidities that impact on health and survival.:@0.519047:0.276309:0.858621:0.276309:0.858621:0.260527:0.519047:0.260527:0.014182:0.009903:0.004551:0.010311:0.003024:0.010357:0.003024:0.005125:0.003024:0.009827:0.005866:0.004188:0.005125:0.009223:0.010326:0.005125:0.004188:0.003024:0.014182:0.010311:0.010326:0.009782:0.005125:0.004188:0.009903:0.009223:0.004188:0.009223:0.009827:0.010326:0.003024:0.005125:0.009223:0.004188:0.010326:0.009223:0.010357:0.004188:0.005866:0.009192:0.004551:0.008376:0.003024:0.008376:0.010326:0.003024:0.004188
1:@0.858613:0.271013:0.863471:0.271013:0.863471:0.261859:0.858613:0.261859:0.004858
•  Lung:  Lung  cancer  is  the  most  common  cause  of :@0.519047:0.290550:0.927987:0.290550:0.927987:0.274767:0.519047:0.274767:0.009162:0.004188:0.006804:0.006985:0.009192:0.009223:0.010175:0.004188:0.004188:0.003402:0.006985:0.009192:0.009223:0.010175:0.004188:0.003417:0.009782:0.010326:0.009223:0.009782:0.009827:0.004551:0.004188:0.003417:0.003024:0.005866:0.004188:0.003417:0.005125:0.009223:0.009827:0.004188:0.003417:0.014182:0.009903:0.005866:0.005125:0.004188:0.003417:0.009782:0.009903:0.014182:0.014182:0.009903:0.009223:0.004188:0.003402:0.009782:0.010326:0.009192:0.005866:0.009827:0.004188:0.003417:0.009903:0.004747:0.004188
death in COpD, and its incidence is increased two :@0.539201:0.304785:0.927987:0.304785:0.927987:0.289003:0.539201:0.289003:0.010357:0.009827:0.010326:0.005125:0.009223:0.006305:0.003024:0.009223:0.006305:0.012292:0.013138:0.008950:0.011249:0.004188:0.006305:0.010326:0.009223:0.010357:0.006305:0.003024:0.005125:0.005866:0.006305:0.003024:0.009223:0.009782:0.003024:0.010357:0.009827:0.009223:0.009782:0.009827:0.006290:0.003024:0.005866:0.006305:0.003024:0.009223:0.009782:0.004551:0.009827:0.010326:0.005866:0.009827:0.010357:0.006305:0.005125:0.012564:0.009903:0.004188
to four times with linear increases in proportion to the :@0.539201:0.319021:0.928002:0.319021:0.928002:0.303238:0.539201:0.303238:0.005125:0.009903:0.004082:0.004747:0.009903:0.009192:0.004551:0.004067:0.005125:0.003024:0.014182:0.009827:0.005866:0.004082:0.012564:0.003024:0.005125:0.009223:0.004082:0.003024:0.003024:0.009223:0.009827:0.010326:0.004551:0.004082:0.003024:0.009223:0.009782:0.004551:0.009827:0.010326:0.005866:0.009827:0.005866:0.004082:0.003024:0.009223:0.004082:0.010311:0.004551:0.009903:0.010311:0.009903:0.004551:0.005125:0.003024:0.009903:0.009223:0.004067:0.005125:0.009903:0.004082:0.005125:0.009223:0.009827:0.004188
severity of the FEV .  There  is an increased rate of :@0.539201:0.333256:0.927982:0.333263:0.927982:0.317481:0.539201:0.317474:0.005866:0.009827:0.008376:0.009827:0.004551:0.003024:0.005125:0.008104:0.006743:0.009903:0.004747:0.006743:0.005125:0.009223:0.009827:0.006743:0.007333:0.008104:0.010614:0.004868:0.004188:0.009717:0.006743:0.006441:0.009223:0.009827:0.004551:0.009827:0.004188:0.002540:0.003024:0.005866:0.006743:0.010326:0.009223:0.006743:0.003024:0.009223:0.009782:0.004551:0.009827:0.010326:0.005866:0.009827:0.010357:0.006743:0.004551:0.010326:0.005125:0.009827:0.006743:0.009903:0.004747:-0.030019
1:@0.679015:0.332929:0.683873:0.332929:0.683873:0.323775:0.679015:0.323775:0.004858
15:@0.688060:0.327965:0.697776:0.327965:0.697776:0.318811:0.688060:0.318811:0.004858:0.004858
bronchiectasis among COpD patients.:@0.539211:0.347499:0.820063:0.347499:0.820063:0.331716:0.539211:0.331716:0.010311:0.004551:0.009903:0.009223:0.009782:0.009223:0.003024:0.009827:0.009782:0.005125:0.010326:0.005866:0.003024:0.005866:0.004188:0.010326:0.014182:0.009903:0.009223:0.010175:0.004188:0.012292:0.013138:0.008950:0.011249:0.004188:0.010311:0.010326:0.005125:0.003024:0.009827:0.009223:0.005125:0.005866:0.004188
•  Cardiovascular disease: COPD is associated with an :@0.519058:0.361735:0.927997:0.361735:0.927997:0.345952:0.519058:0.345952:0.009162:0.004188:0.006804:0.012292:0.010326:0.004551:0.010357:0.003024:0.009903:0.008376:0.010326:0.005866:0.009782:0.009192:0.003024:0.010326:0.004551:0.004838:0.010357:0.003024:0.005866:0.009827:0.010326:0.005866:0.009827:0.004188:0.004838:0.012292:0.013138:0.008950:0.011249:0.004823:0.003024:0.005866:0.004838:0.010326:0.005866:0.005866:0.009903:0.009782:0.003024:0.010326:0.005125:0.009827:0.010357:0.004838:0.012564:0.003024:0.005125:0.009223:0.004838:0.010326:0.009223:0.004188
increased rate of ischaemic heart disease, atrial fibril:@0.539211:0.375970:0.918790:0.375970:0.918790:0.360187:0.539211:0.360187:0.003024:0.009223:0.009782:0.004551:0.009827:0.010326:0.005866:0.009827:0.010357:0.003477:0.004551:0.010326:0.005125:0.009827:0.003462:0.009903:0.004747:0.003462:0.003024:0.005866:0.009782:0.009223:0.010326:0.009827:0.014182:0.003024:0.009782:0.003477:0.009223:0.009827:0.010326:0.004551:0.005125:0.003462:0.010357:0.003024:0.005866:0.009827:0.010326:0.005866:0.009827:0.004188:0.003477:0.010326:0.005125:0.004551:0.003024:0.010326:0.003024:0.003477:0.003681:0.003681:0.010311:0.004551:0.003024:0.003024
-:@0.918790:0.375970:0.923809:0.375970:0.923809:0.360187:0.918790:0.360187:0.005020
lation, hypertension, systolic and diastolic failure.:@0.539211:0.390206:0.893269:0.390206:0.893269:0.374423:0.539211:0.374423:0.003024:0.010326:0.005125:0.003024:0.009903:0.009223:0.004188:0.004188:0.009223:0.008104:0.010311:0.009827:0.004551:0.005125:0.009827:0.009223:0.005866:0.003024:0.009903:0.009223:0.004188:0.004188:0.005866:0.008104:0.005866:0.005125:0.009903:0.003024:0.003024:0.009782:0.004188:0.010326:0.009223:0.010357:0.004188:0.010357:0.003024:0.010326:0.005866:0.005125:0.009903:0.003024:0.003024:0.009782:0.004188:0.004747:0.010326:0.003024:0.003024:0.009192:0.004551:0.009827:0.004188
•  Osteoporosis, diabetes, depression and anxiety and :@0.519058:0.404441:0.928013:0.404441:0.928013:0.388659:0.519058:0.388659:0.009162:0.004188:0.006804:0.013138:0.005866:0.005125:0.009827:0.009903:0.010311:0.009903:0.004551:0.009903:0.005866:0.003024:0.005866:0.004188:0.005367:0.010357:0.003024:0.010326:0.010311:0.009827:0.005125:0.009827:0.005866:0.004188:0.005367:0.010357:0.009827:0.010311:0.004551:0.009827:0.005866:0.005866:0.003024:0.009903:0.009223:0.005367:0.010326:0.009223:0.010357:0.005367:0.010326:0.009223:0.007257:0.003024:0.009827:0.005125:0.008104:0.005367:0.010326:0.009223:0.010357:0.004188
peripheral vascular disease are all diseases encoun-:@0.539211:0.418677:0.923809:0.418677:0.923809:0.402894:0.539211:0.402894:0.010311:0.009827:0.004551:0.003024:0.010311:0.009223:0.009827:0.004551:0.010326:0.003024:0.004808:0.008376:0.010326:0.005866:0.009782:0.009192:0.003024:0.010326:0.004551:0.004808:0.010357:0.003024:0.005866:0.009827:0.010326:0.005866:0.009827:0.004823:0.010326:0.004551:0.009827:0.004808:0.010326:0.003024:0.003024:0.004823:0.010357:0.003024:0.005866:0.009827:0.010326:0.005866:0.009827:0.005866:0.004823:0.009827:0.009223:0.009782:0.009903:0.009192:0.009207:0.005020
tered  more  frequently in COpD patients. Gastro-:@0.539211:0.432912:0.923825:0.432912:0.923825:0.417130:0.539211:0.417130:0.005125:0.009827:0.004551:0.009827:0.010357:0.004188:0.005413:0.014182:0.009903:0.004551:0.009827:0.004188:0.005413:0.004747:0.004551:0.009827:0.010311:0.009192:0.009827:0.009223:0.005125:0.003024:0.008104:0.009616:0.003024:0.009223:0.009616:0.012292:0.013138:0.008950:0.011249:0.009616:0.010311:0.010326:0.005125:0.003024:0.009827:0.009223:0.005125:0.005866:0.004188:0.009616:0.013184:0.010326:0.005866:0.005125:0.004551:0.009903:0.005020
oesophageal  reflux  disease  (GORD)  results  in  more :@0.539211:0.447148:0.928013:0.447148:0.928013:0.431365:0.539211:0.431365:0.009903:0.009827:0.005866:0.009903:0.010311:0.009223:0.010326:0.010175:0.009827:0.010326:0.003024:0.004188:0.002570:0.004551:0.009827:0.003666:0.003666:0.009192:0.007257:0.004188:0.002570:0.010357:0.003024:0.005866:0.009827:0.010326:0.005866:0.009827:0.004188:0.002585:0.005579:0.013184:0.013138:0.009177:0.011249:0.005579:0.004188:0.002585:0.004551:0.009827:0.005866:0.009192:0.003024:0.005125:0.005866:0.004188:0.002570:0.003024:0.009223:0.004188:0.002570:0.014182:0.009903:0.004551:0.009827:0.004188
acute exacerbations of COpD.:@0.539211:0.461383:0.765846:0.461383:0.765846:0.445601:0.539211:0.445601:0.010326:0.009782:0.009192:0.005125:0.009827:0.004188:0.009827:0.007257:0.010326:0.009782:0.009827:0.004551:0.010311:0.010326:0.005125:0.003024:0.009903:0.009223:0.005866:0.004188:0.009903:0.004747:0.004188:0.012292:0.013138:0.008950:0.011249:0.004188
ACute exACerbAtiOns AnD mAnAGement:@0.519047:0.494390:0.909320:0.494390:0.909320:0.474225:0.519047:0.474225:0.013674:0.014413:0.011826:0.007761:0.009609:0.005174:0.009609:0.012566:0.013674:0.014413:0.009609:0.010718:0.010718:0.013674:0.007761:0.005174:0.015522:0.013674:0.009609:0.005174:0.013674:0.013674:0.012935:0.005174:0.016631:0.013674:0.013674:0.013674:0.015522:0.009609:0.016631:0.009609:0.013674:0.007761
Bacterial and viral infections, particularly the :@0.519047:0.510406:0.855431:0.510406:0.855431:0.494623:0.519047:0.494623:0.008376:0.010024:0.009480:0.004823:0.009525:0.004248:0.002721:0.010024:0.002721:0.008376:0.010024:0.008920:0.010054:0.008376:0.008074:0.002721:0.004248:0.010024:0.002721:0.008376:0.002721:0.008920:0.004445:0.009525:0.009480:0.004823:0.002721:0.009601:0.008920:0.005564:0.003886:0.008376:0.010009:0.010024:0.004248:0.004823:0.002721:0.009480:0.008890:0.002721:0.010024:0.004248:0.002721:0.007801:0.008376:0.004823:0.008920:0.009525:0.004188
rhinovirus :@0.859619:0.510406:0.928017:0.510406:0.928017:0.494623:0.859619:0.494623:0.004248:0.008920:0.002721:0.008920:0.009601:0.008074:0.002721:0.004248:0.008890:0.005866:0.004188
(the common cold) and noxious particle inhalation can :@0.519047:0.524641:0.928047:0.524641:0.928047:0.508859:0.519047:0.508859:0.005277:0.004823:0.008920:0.009525:0.005836:0.009480:0.009601:0.013879:0.013879:0.009601:0.008920:0.005836:0.009480:0.009601:0.002721:0.010054:0.005277:0.005836:0.010024:0.008920:0.010054:0.005836:0.008920:0.009601:0.006955:0.002721:0.009601:0.008890:0.005564:0.005836:0.010009:0.010024:0.004248:0.004823:0.002721:0.009480:0.002721:0.009525:0.005836:0.002721:0.008920:0.008920:0.010024:0.002721:0.010024:0.004823:0.002721:0.009601:0.008920:0.005836:0.009480:0.010024:0.009223:0.004188
precipitate an exacerbation.  Consequently, increased :@0.519047:0.538877:0.928005:0.538882:0.928005:0.523099:0.519047:0.523094:0.010009:0.004248:0.009525:0.009480:0.002721:0.010009:0.002721:0.004823:0.010024:0.004823:0.009525:0.007741:0.010024:0.008920:0.007741:0.009525:0.006955:0.010024:0.009480:0.009525:0.004248:0.010009:0.010024:0.004823:0.002721:0.009601:0.008920:0.004188:0.004373:0.007741:0.011989:0.009601:0.008920:0.005564:0.009525:0.010009:0.008890:0.009525:0.008920:0.004823:0.002721:0.007801:0.003886:0.007741:0.002721:0.008920:0.009480:0.004248:0.009525:0.010024:0.005564:0.009525:0.010357:-0.299304
1:@0.731112:0.533583:0.735971:0.533583:0.735971:0.524429:0.731112:0.524429:0.004858
mucus production and narrowing of the airways as a result :@0.519050:0.553117:0.928051:0.553117:0.928051:0.537335:0.519050:0.537335:0.013879:0.008890:0.009480:0.008890:0.005564:0.003145:0.010009:0.004248:0.009601:0.010054:0.008890:0.009480:0.004823:0.002721:0.009601:0.008920:0.003145:0.010024:0.008920:0.010054:0.003145:0.008920:0.010024:0.004248:0.004248:0.009601:0.012262:0.002721:0.008920:0.009873:0.003145:0.009601:0.004445:0.003145:0.004823:0.008920:0.009525:0.003145:0.010024:0.002721:0.004248:0.012262:0.010024:0.007801:0.005564:0.003145:0.010024:0.005564:0.003145:0.010024:0.003145:0.004248:0.009525:0.005564:0.008890:0.002721:0.005125:0.004188
of inflammation, result in air-trapping and increased dysp:@0.519050:0.567353:0.919055:0.567353:0.919055:0.551570:0.519050:0.551570:0.009601:0.004445:0.003855:0.002721:0.008920:0.003515:0.003515:0.010024:0.013879:0.013879:0.010024:0.004823:0.002721:0.009601:0.008920:0.003886:0.003855:0.004248:0.009525:0.005564:0.008890:0.002721:0.004823:0.003855:0.002721:0.008920:0.003855:0.010024:0.002721:0.004248:0.004717:0.004823:0.004248:0.010024:0.010009:0.010009:0.002721:0.008920:0.009873:0.003855:0.010024:0.008920:0.010054:0.003855:0.002721:0.008920:0.009480:0.004248:0.009525:0.010024:0.005564:0.009525:0.010054:0.003855:0.010054:0.007801:0.005564:0.010311
-:@0.918752:0.567353:0.923772:0.567353:0.923772:0.551570:0.918752:0.551570:0.005020
noea.  Why some patients are prone to exacerbations is :@0.519050:0.581588:0.928038:0.581596:0.928038:0.565813:0.519050:0.565806:0.008920:0.009601:0.009525:0.010024:0.004188:0.004372:0.005216:0.014212:0.008920:0.007801:0.005216:0.005564:0.009601:0.013879:0.009525:0.005216:0.010009:0.010024:0.004823:0.002721:0.009525:0.008920:0.004823:0.005564:0.005216:0.010024:0.004248:0.009525:0.005216:0.010009:0.004248:0.009601:0.008920:0.009525:0.005216:0.004823:0.009601:0.005216:0.009525:0.006955:0.010024:0.009480:0.009525:0.004248:0.010009:0.010024:0.004823:0.002721:0.009601:0.008920:0.005564:0.005216:0.002721:0.005866:-0.355271
1:@0.560995:0.576297:0.565853:0.576297:0.565853:0.567143:0.560995:0.567143:0.004858
not known. However, the most significant predictor of an :@0.519053:0.595831:0.928068:0.595831:0.928068:0.580048:0.519053:0.580048:0.008920:0.009601:0.004823:0.004778:0.007287:0.008920:0.009601:0.012262:0.008920:0.003886:0.004778:0.010024:0.009601:0.012262:0.009525:0.008074:0.009525:0.004248:0.003886:0.004778:0.004823:0.008920:0.009525:0.004778:0.013879:0.009601:0.005564:0.004823:0.004778:0.005564:0.002721:0.009873:0.008920:0.002721:0.003530:0.003530:0.009480:0.010024:0.008920:0.004823:0.004778:0.010009:0.004248:0.009525:0.010054:0.002721:0.009480:0.004823:0.009601:0.004248:0.004778:0.009601:0.004445:0.004778:0.010024:0.009223:0.004188
exacerbation is previous exacerbations, even though ex-:@0.519053:0.610067:0.923819:0.610067:0.923819:0.594284:0.519053:0.594284:0.009525:0.006955:0.010024:0.009480:0.009525:0.004248:0.010009:0.010024:0.004823:0.002721:0.009601:0.008920:0.004687:0.002721:0.005564:0.004687:0.010009:0.004248:0.009525:0.008074:0.002721:0.009601:0.008890:0.005564:0.004687:0.009525:0.006955:0.010024:0.009480:0.009525:0.004248:0.010009:0.010024:0.004823:0.002721:0.009601:0.008920:0.005564:0.003886:0.004687:0.009525:0.008074:0.009525:0.008920:0.004687:0.004823:0.008920:0.009601:0.008890:0.009873:0.008920:0.004687:0.009525:0.006955:0.005020
acerbations also increase with the severity of COpD.:@0.519053:0.624302:0.886037:0.624302:0.886037:0.608520:0.519053:0.608520:0.010024:0.009480:0.009525:0.004248:0.010009:0.010024:0.004823:0.002721:0.009601:0.008920:0.005564:0.003886:0.010024:0.002721:0.005564:0.009601:0.003886:0.002721:0.008920:0.009480:0.004248:0.009525:0.010024:0.005564:0.009525:0.003886:0.012262:0.002721:0.004823:0.008920:0.003886:0.004823:0.008920:0.009525:0.003886:0.005564:0.009525:0.008074:0.009525:0.004248:0.002721:0.004823:0.007801:0.003886:0.009601:0.004445:0.003886:0.011989:0.012836:0.008648:0.010946:0.004188
16:@0.885707:0.619011:0.895247:0.619011:0.895247:0.609857:0.885707:0.609857:0.004683:0.004858
While the majority of exacerbations can be treat-:@0.533333:0.638547:0.923812:0.638547:0.923812:0.622765:0.533333:0.622765:0.014514:0.009223:0.003024:0.003024:0.009827:0.008421:0.005125:0.009223:0.009827:0.008421:0.014182:0.010326:0.003069:0.009903:0.004551:0.003024:0.005125:0.008104:0.008421:0.009903:0.004747:0.008421:0.009827:0.007257:0.010326:0.009782:0.009827:0.004551:0.010311:0.010326:0.005125:0.003024:0.009903:0.009223:0.005866:0.008421:0.009782:0.010326:0.009223:0.008421:0.010311:0.009827:0.008421:0.005125:0.004551:0.009827:0.010326:0.005140:0.005020
ed at home  with antibiotics, steroids and short-acting :@0.519045:0.652783:0.928015:0.652783:0.928015:0.637000:0.519045:0.637000:0.009827:0.010357:0.006486:0.010326:0.005125:0.006486:0.009223:0.009903:0.014182:0.009827:0.004188:0.002283:0.012564:0.003024:0.005125:0.009223:0.006486:0.010326:0.009223:0.005125:0.003024:0.010311:0.003024:0.009903:0.005125:0.003024:0.009782:0.005866:0.004188:0.006486:0.005866:0.005125:0.009827:0.004551:0.009903:0.003024:0.010357:0.005866:0.006486:0.010326:0.009223:0.010357:0.006486:0.005866:0.009223:0.009903:0.004551:0.005125:0.005020:0.010326:0.009782:0.005125:0.003024:0.009223:0.010175:0.004188
bronchodilators  (level I exacerbation),  those  with the :@0.519045:0.667018:0.928000:0.667018:0.928000:0.651236:0.519045:0.651236:0.010311:0.004551:0.009903:0.009223:0.009782:0.009223:0.009903:0.010357:0.003024:0.003024:0.010326:0.005125:0.009903:0.004551:0.005866:0.004188:0.003024:0.005579:0.003024:0.009827:0.008376:0.009827:0.003024:0.007227:0.003417:0.007227:0.009827:0.007257:0.010326:0.009782:0.009827:0.004551:0.010311:0.010326:0.005125:0.003024:0.009903:0.009223:0.005579:0.004188:0.004188:0.003024:0.005125:0.009223:0.009903:0.005866:0.009827:0.004188:0.003024:0.012564:0.003024:0.005125:0.009223:0.007227:0.005125:0.009223:0.009827:0.004188
following clinical signs and symptoms require hospital :@0.519045:0.681254:0.927985:0.681254:0.927985:0.665471:0.519045:0.665471:0.004747:0.009903:0.003024:0.003024:0.009903:0.012564:0.003024:0.009223:0.010175:0.007045:0.009782:0.003024:0.003024:0.009223:0.003024:0.009782:0.010326:0.003024:0.007045:0.005866:0.003024:0.010175:0.009223:0.005866:0.007045:0.010326:0.009223:0.010357:0.007045:0.005866:0.008104:0.014182:0.010311:0.005125:0.009903:0.014182:0.005866:0.007045:0.004551:0.009827:0.010311:0.009192:0.003024:0.004551:0.009827:0.007045:0.009223:0.009903:0.005866:0.010311:0.003024:0.005125:0.010326:0.003024:0.004188
admission (level II and III).:@0.519045:0.695616:0.703982:0.695616:0.703982:0.679834:0.519045:0.679834:0.010326:0.010357:0.014182:0.003024:0.005866:0.005866:0.003024:0.009903:0.009223:0.004188:0.005579:0.003024:0.009827:0.008376:0.009827:0.003024:0.004188:0.003417:0.003417:0.004188:0.010326:0.009223:0.010357:0.004188:0.003417:0.003417:0.003417:0.005579:0.004188
1:@0.703997:0.690329:0.708855:0.690329:0.708855:0.681175:0.703997:0.681175:0.004858
Hospital admission criteria::@0.519047:0.717434:0.714385:0.717434:0.714385:0.700935:0.519047:0.700935:0.010281:0.009676:0.006652:0.009979:0.003629:0.004536:0.009979:0.003629:0.004233:0.009979:0.009979:0.014212:0.003629:0.006652:0.006652:0.003629:0.009676:0.009071:0.004233:0.009676:0.004838:0.003629:0.004536:0.009676:0.004838:0.003629:0.009979:0.004233
•  Poor response to antibiotics, steroids and SABAs:@0.519047:0.731542:0.885835:0.731542:0.885835:0.715760:0.519047:0.715760:0.009162:0.004188:0.006804:0.008950:0.009903:0.009903:0.004551:0.004188:0.004551:0.009827:0.005866:0.010311:0.009903:0.009223:0.005866:0.009827:0.004188:0.005125:0.009903:0.004188:0.010326:0.009223:0.005125:0.003024:0.010311:0.003024:0.009903:0.005125:0.003024:0.009782:0.005866:0.004188:0.004188:0.005866:0.005125:0.009827:0.004551:0.009903:0.003024:0.010357:0.005866:0.004188:0.010326:0.009223:0.010357:0.004188:0.007529:0.011188:0.008678:0.011188:0.005866
•  Sudden, severe symptoms which may be accompa:@0.519047:0.745651:0.918780:0.745651:0.918780:0.729868:0.519047:0.729868:0.009162:0.004188:0.006804:0.007529:0.009192:0.010357:0.010357:0.009827:0.009223:0.004188:0.004309:0.005866:0.009827:0.008376:0.009827:0.004551:0.009827:0.004309:0.005866:0.008104:0.014182:0.010311:0.005125:0.009903:0.014182:0.005866:0.004324:0.012564:0.009223:0.003024:0.009782:0.009223:0.004324:0.014182:0.010326:0.008104:0.004324:0.010311:0.009827:0.004324:0.010326:0.009782:0.009782:0.009903:0.014182:0.010311:0.010326
-:@0.918780:0.745651:0.923799:0.745651:0.923799:0.729868:0.918780:0.729868:0.005020
nied by confusion and drowsiness:@0.539201:0.759759:0.784613:0.759759:0.784613:0.743977:0.539201:0.743977:0.009223:0.003024:0.009827:0.010357:0.004188:0.010311:0.008104:0.004188:0.009782:0.009903:0.009223:0.004747:0.009192:0.005866:0.003024:0.009903:0.009223:0.004188:0.010326:0.009223:0.010357:0.004188:0.010357:0.004551:0.009903:0.012564:0.005866:0.003024:0.009223:0.009827:0.005866:0.005866
Dyspnoea:@0.090049:0.801850:0.164435:0.801850:0.164435:0.785352:0.090049:0.785352:0.010583:0.008769:0.006652:0.009979:0.009071:0.009676:0.009676:0.009979
exacerbations:@0.604097:0.801850:0.708116:0.801850:0.708116:0.785352:0.604097:0.785352:0.007862:0.008467:0.009979:0.009676:0.009676:0.004838:0.009979:0.009979:0.004536:0.003629:0.009676:0.009071:0.006652
1. LAMA or LABA :@0.090049:0.818133:0.201218:0.818133:0.201218:0.804104:0.090049:0.804104:0.007445:0.003723:0.003723:0.006209:0.009945:0.012351:0.009945:0.003723:0.008803:0.004045:0.003723:0.006209:0.009945:0.007714:0.009945:0.003723
1. LAMA or LABA:@0.604097:0.818133:0.711543:0.818133:0.711543:0.804104:0.604097:0.804104:0.007445:0.003723:0.003723:0.006209:0.009945:0.012351:0.009945:0.003723:0.008803:0.004045:0.003723:0.006209:0.009945:0.007714:0.009945
2. LAMA + LABA :@0.090049:0.834810:0.196514:0.834810:0.196514:0.820781:0.090049:0.820781:0.007445:0.003723:0.003723:0.006209:0.009945:0.012351:0.009945:0.003723:0.008144:0.003723:0.006209:0.009945:0.007714:0.009945:0.003723
2. LAMA + LABA or:@0.604097:0.834810:0.723409:0.834810:0.723409:0.820781:0.604097:0.820781:0.007445:0.003723:0.003723:0.006209:0.009945:0.012351:0.009945:0.003723:0.008144:0.003723:0.006209:0.009945:0.007714:0.009945:0.003723:0.008803:0.004045
3. Change to different drugs keeping :@0.090049:0.851487:0.334790:0.851487:0.334790:0.837458:0.090049:0.837458:0.007445:0.003723:0.003723:0.010926:0.008198:0.009179:0.008198:0.009045:0.008735:0.003723:0.004556:0.008803:0.003723:0.009206:0.002688:0.004220:0.004220:0.008735:0.004045:0.008735:0.008198:0.004556:0.003723:0.009206:0.004045:0.008171:0.009045:0.005214:0.003723:0.006746:0.008735:0.008735:0.009165:0.002688:0.008198:0.009045:0.003723
3. LABA + ICs (eosinophils >300):@0.604097:0.851487:0.807270:0.851487:0.807270:0.837458:0.604097:0.837458:0.007445:0.003723:0.003723:0.006209:0.009945:0.007714:0.009945:0.003723:0.008144:0.003723:0.003037:0.010926:0.006693:0.003723:0.004959:0.008735:0.008803:0.005214:0.002688:0.008198:0.008803:0.009165:0.008198:0.002688:0.002688:0.005214:0.003709:0.008144:0.007445:0.007445:0.007445:0.004959
    the LAMA LABA combination :@0.090049:0.868163:0.297160:0.868163:0.297160:0.854134:0.090049:0.854134:0.003723:0.003723:0.003723:0.003723:0.004556:0.008198:0.008735:0.003723:0.006209:0.009945:0.012351:0.009945:0.003723:0.006209:0.009945:0.007714:0.009945:0.003723:0.008695:0.008803:0.012606:0.009165:0.002688:0.008198:0.009179:0.004556:0.002688:0.008803:0.008198:0.003723
4. LABA + LAMA + ICs:@0.604097:0.868163:0.743084:0.868163:0.743084:0.854134:0.604097:0.854134:0.007445:0.003723:0.003723:0.006209:0.009945:0.007714:0.009945:0.003723:0.008144:0.003723:0.006209:0.009945:0.012351:0.009945:0.003723:0.008144:0.003723:0.003037:0.010926:0.006693
4. Investigate other causes for dyspnoea :@0.090049:0.884840:0.357260:0.884840:0.357260:0.870811:0.090049:0.870811:0.007445:0.003723:0.003723:0.003037:0.008198:0.007445:0.008735:0.005214:0.004556:0.002688:0.009045:0.009179:0.004556:0.008735:0.003723:0.008803:0.004556:0.008198:0.008735:0.004045:0.003723:0.008695:0.009179:0.008171:0.005214:0.008735:0.005214:0.003723:0.004220:0.008803:0.004045:0.003723:0.009206:0.007203:0.005214:0.009165:0.008198:0.008803:0.008735:0.009179:0.003723
5. Roflumilast:@0.604097:0.884840:0.687567:0.884840:0.687567:0.870811:0.604097:0.870811:0.007445:0.003723:0.003723:0.008158:0.008803:0.003259:0.003259:0.008171:0.012606:0.002688:0.002688:0.009179:0.005214:0.004556
5. Consider LAMA + LABA+ ICs :@0.090049:0.901517:0.290575:0.901517:0.290575:0.887488:0.090049:0.887488:0.007445:0.003723:0.003723:0.010926:0.008803:0.008198:0.005214:0.002688:0.009206:0.008735:0.004045:0.003723:0.006209:0.009945:0.012351:0.009945:0.003723:0.008144:0.003723:0.006209:0.009945:0.007714:0.009945:0.008144:0.003723:0.003037:0.010926:0.006693:0.003723
6. Azithromycin:@0.604097:0.901517:0.702323:0.901517:0.702323:0.887488:0.604097:0.887488:0.007445:0.003723:0.003723:0.009945:0.005712:0.002688:0.004556:0.008198:0.004045:0.008803:0.012606:0.007203:0.008695:0.002688:0.008198
Consider de-escalating ICS if pneumonia or no response :@0.329360:0.918183:0.639845:0.918183:0.639845:0.904380:0.329360:0.904380:0.006975:0.007082:0.007082:0.005295:0.003306:0.007096:0.006599:0.004731:0.003037:0.007096:0.006599:0.004112:0.006599:0.005295:0.005429:0.007096:0.003306:0.007096:0.003931:0.003931:0.007082:0.007096:0.003037:0.003588:0.006975:0.006249:0.003037:0.003306:0.004247:0.003037:0.007096:0.007082:0.006599:0.007082:0.010805:0.007082:0.007082:0.003306:0.007096:0.003037:0.007082:0.004731:0.003037:0.007082:0.007082:0.003037:0.004731:0.006599:0.005295:0.007096:0.007082:0.007082:0.005295:0.006599:0.003037
to :@0.639885:0.918625:0.654682:0.918625:0.654682:0.904380:0.639885:0.904380:0.004529:0.007230:0.003037
ICS:@0.654682:0.918183:0.671494:0.918183:0.671494:0.904380:0.654682:0.904380:0.003588:0.006975:0.006249
table 2. A stepwise approach to continuing symptoms :@0.076190:0.944822:0.475892:0.944822:0.475892:0.928323:0.076190:0.928323:0.006350:0.009979:0.009979:0.003629:0.009676:0.004233:0.008467:0.004233:0.004188:0.011188:0.004233:0.006652:0.004536:0.009676:0.009979:0.012095:0.003629:0.006652:0.009676:0.004233:0.009979:0.009979:0.009979:0.004838:0.009676:0.009979:0.009676:0.009071:0.004233:0.004536:0.009676:0.004233:0.009676:0.009676:0.009071:0.004536:0.003629:0.009071:0.009071:0.003629:0.009071:0.009979:0.004233:0.006652:0.008769:0.014212:0.009979:0.004536:0.009676:0.014212:0.006652:0.004233
 :@0.132736:0.944822:0.136924:0.944822:0.136924:0.929039:0.132736:0.929039:0.004188